Carregant...

Respiratory Syncytial Virus Infection in High-risk Infants – an Update on Palivizumab Prophylaxis

Morbidity due to respiratory syncytial virus (RSV) disease is still high in infants and children worldwide during the first two to five years of life. Certain categories of high-risk infants with increased morbidity and mortality attributed to RSV disease have been identified and are included in nat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Resch, Bernhard
Format: Artigo
Idioma:Inglês
Publicat: Bentham Open 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4133922/
https://ncbi.nlm.nih.gov/pubmed/25132870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874285801408010071
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!